Interleukin 1 Receptor-Like 1 Protein (ST2) is a Potential Biomarker for Cardiomyopathy in Duchenne Muscular Dystrophy

Julia Anderson, Haeri Seol, Heather Gordish-Dressman, Yetrib Hathout, Christopher F. Spurney, C. McDonald, R. T. Abresch, E. Henricson, M. Cregan, E. Goude, L. Johnson, J. Han, N. Joyce, D. Reedy, V. Viswanathan, C. Chidambaranathan, S. Kumar, V. Lakshmi, P. Reddappa, D. BiggarL. McAdam, M. Dermody, L. Eliasoph, V. Harris, G. Lee, J. Mah, A. Chiu, T. Haig, M. Harris, K. Sanchez, J. Thannhauser, L. Walker, C. Wright, M. Tulinius, A. Alhander, A. Ekstrom, A. Gustafsson, A. Kroksmark, U. Sterky, L. Wahlgren, M. Thangarajh, M. Birkmeier, S. Kaminski, B. Tadesse, A. Toles, A. Kornberg, M. Ryan, K. Carroll, K. DeValle, J. Day, On behalf of the CINRG Investigators

Research output: Contribution to journalArticlepeer-review

15 Scopus citations

Fingerprint

Dive into the research topics of 'Interleukin 1 Receptor-Like 1 Protein (ST2) is a Potential Biomarker for Cardiomyopathy in Duchenne Muscular Dystrophy'. Together they form a unique fingerprint.

Keyphrases

Pharmacology, Toxicology and Pharmaceutical Science